Direkt zum Inhalt
Merck

[The calcipotriol-betamethasone dipropionate association].

Revue medicale de Liege (2006-01-13)
F Henry, C Flagothier, P Delvoye, C Piérard-Franchimont, G E Piérard
ZUSAMMENFASSUNG

The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Betamethason, ≥98%
USP
Betamethasondipropionat, United States Pharmacopeia (USP) Reference Standard
Supelco
Betamethasondipropionat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Betamethason, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Betamethason-17,21-Dipropionat
Supelco
Betamethason, VETRANAL®, analytical standard
Betamethasondipropionat, European Pharmacopoeia (EP) Reference Standard
Betamethason, European Pharmacopoeia (EP) Reference Standard
Betamethasondipropionat für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard